HB 876 Virginia House of Delegates · 2020 Regular Session

Prescription drugs; price transparency.

Summary
Prescription drug price transparency. Requiresevery health carrier, pharmacy benefits manager, wholesale drug distributer, and drug manufacturer to report information about prescription drugprices and related information to the Department of Health and requiresthe Department to make such information available on its website.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2020
Committee Review
Floor Vote
Governor
Introduced Jan 7, 2020 Last action Feb 4, 2020
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
7
Key actions
2
Committee
4
Jan 30, 2020
Lower · Passed
Subcommittee recommends continuing to 2021
lower
Jan 30, 2020
Lower · Passed
House committee, floor amendments and substitutes offered
lower
Jan 17, 2020
Committee
Assigned HWI sub: Health Professions
lower
Jan 7, 2020
Committee
Referred to Committee on Health, Welfare and Institutions
lower
Jan 7, 2020
Introduced
Prefiled and ordered printed; offered 01/08/20 20104912D
lower
1 primary · 2 co-sponsors

Sponsors